FDA orders all ranitidine drugs to be pulled from market immediately
Updated : April 02, 2020 09:49 AM IST
This is the latest step in an ongoing investigation to determined the levels of a contaminant known as N-Nitrosodimethylamine.
It has advised companies not meeting the limits of NDMA in Rantidine to recall it.
USFDA had in September 2019 sounded an alert on the presence of NDMA in Ranitidine.